GlassScriptPhysician profile
Celia K Stephens
NPI 1770676504
$1,737.71
in general payments reported to CMS, 2019-2025
18 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.96 · 2022: $139 · 2023: $342 · 2024: $855 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,515.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $583.42 | 2021-2024 | Qelbree, Qelbree |
| Corium, LLC | $232.76 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $225.27 | 2022-2024 | Jornay Pm |
| Pfizer INC. | $141.94 | 2023-2025 | |
| Tris Pharma INC | $94.97 | 2021-2025 | Dyanavel Xr |
| Cranial Technologies, INC | $94.50 | 2024-2025 | Doc Band |
| Sanofi Pasteur INC. | $87.34 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $55.42 | 2023-2025 | |
| Glaxosmithkline, LLC. | $46.00 | 2023-2024 | Bexsero, Rotarix, Pediarix |
| Collegium Pharmaceutical, INC. | $41.86 | 2025 | Jornay Pm |
| Lundbeck LLC | $32.97 | 2025 | Vyepti |
| Verrica Pharmaceuticals INC. | $16.84 | 2024 | Ycanth |
| Lnhc, INC | $15.26 | 2025 | Zelsuvmi |
| Shield Therapeutics INC | $15.07 | 2023 | |
| Noven Therapeutics, LLC | $15.04 | 2025 | Xelstrym |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $14.91 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.17 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celia Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.